RESULTS
Our fi ndings underline that indeed autophagy is critical for maintenance of muscle mass in DD and GSD2 and that alterations of pathways related to endosome traffi cking and lysosomal biogenesis are major pathogenetic mechanisms that contribute to muscle wasting and weakness in GSD2 and DD disease. In particular, alterations of VPS15/VPS34/beclin complex and TFEB transcription factor have been found in GSD2 and DD patients.
CONCLUSIONS
A new perspective emerges from our fi ndings that is focused on signalling perturbation as a pathogenetic mechanism. Autophagosome build-up and lysosome dysfunction impact pathways that, once impaired, greatly contribute to weakness and resistance to therapy in GSD2 and DD patients. Understanding which pathways are the most critical and how to reactivate them are the next most important and challenging issues in order to optimise treatments and counteract disease progression. 
